Top compounds associated with response to ADAD1


Feature Type Standardized
Nominal ANOVA
mRNA tivozanib GDSC1000 pan-cancer AAC -0.0051 0.9
mRNA tosedostat CTRPv2 pan-cancer AAC 0.027 0.5
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.062 0.07
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.036 0.3
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.00084 1
mRNA trifluoperazine CTRPv2 pan-cancer AAC 0.022 0.6
mRNA triptolide CTRPv2 pan-cancer AAC -0.03 0.4
mRNA tubastatin A CTRPv2 pan-cancer AAC 0.051 0.3
mRNA tubastatin A GDSC1000 pan-cancer AAC 0.0026 0.9
mRNA valdecoxib CTRPv2 pan-cancer AAC 0.017 0.6
Download CSV